Dermalyser

AI-powered Dermalyser aids doctors in fast, accurate melanoma diagnosis using dermatoscopic images.

Dermalyser is a clinically validated, AI-powered Medical Device Software (MDSW) designed to support healthcare professionals in diagnosing melanoma. By leveraging advanced artificial intelligence, Dermalyser analyzes dermatoscopic images of skin lesions to provide real-time risk assessments, enabling faster and more accurate diagnoses.

Key Features: High Accuracy: Achieved an AUC score of 0.96 in clinical studies, outperforming expert dermatologists (0.85) and general practitioners (0.70). Ease of Use: Simply attach a dermatoscope to your iPhone, capture an image of a skin lesion, and receive instant AI-driven analysis. Cost Efficiency: Reduces unnecessary skin excisions, improving healthcare economics. Accessibility: Available on iOS, with support for English and Swedish instructions.

Developed with quality-controlled dermatoscopic images and patient data, Dermalyser empowers frontline healthcare practitioners to make reliable diagnostic decisions in seconds, reducing patient wait times and anxiety.